Life Sciences

Marlborough medtech Boston Scientific is hoping to use a portion of the proceeds from a $4.3-billion offering of senior notes to fund its planned acquisition of U.K. cancer and vascular disease firm BTG.

Marlborough biotech Phio Pharmaceuticals CEO Geert Cauwenbergh is retiring, and the company's chief operating officer is taking his place.

Wayland medical aesthetic device company Syneron-Candela has ended a patent dispute with a global competitor after coming to a settlement agreement.

Marlborough medical device company Hologic is raising its full-year expectations after a promising first quarter in which revenue grew 5 percent.

LakePharma company was going to bring 150 jobs to Worcester, but a Chinese competitor took its place after the company decided it couldn't wait any longer and moved to Hopkinton.

Holliston biotech Biostage is planning U.S. regulatory filings to begin marketing its esophagus-regenerating implants after a single-patient case in 2017 proved the company's technology works.

Major biotech player Boston Scientific and its California competitor Edwards Lifesciences are resolving a global patent spat in all courts around the world.

Hologic is expected to shatter its first-quarter revenue estimates by at least $16 million.

Medtech giant Boston Scientific had another growth year in 2018, with preliminary financial information pointing to $9.82 billion in revenue.

Acton-based manufacturer of insulin management systems Insulet Corp. has hired a new chief financial officer.